Barely Significant

Excerpts

514,629 sentences

borderline significancep = 0.040.8× alpha
For [ 18 F]FDG, dyslipidemia and ASA intake remained significant independent predictors of arterial TBR (both p < 0.001), whereas the association with T2DM was attenuated but persisted at borderline significance ( p = 0.04) after multivariable adjustment.
borderline significanceP =0.0400.8× alpha
In the subset of CAA at high hemorrhagic risk, it was classified as A + T − CAA predict time until symptomatic ICH with borderline significance both in the univariate analysis ( P =0.040, by the log‐rank test; HR, 4.44 [95% CI, 0.96–20.59]; P =0.057) and in a multivariate analysis including a previous lobar ICH (HR, 4.01 [95% CI, 0.92–17.44]; P =0.064), but it was an independent predictor in the multivariate model including disseminated cSS (HR, 5.03 [95% CI, 1.10–23.01]; P =0.037).
moderately significantp = 0.040.8× alphaqualifiedgold
Additionally, whilst Refphase’s ability to infer SCNA events at low tumour purities exceeds that of single-sample copy number calling methods ( Fig 4F ), even with Refphase, we observe a moderately significant association between the range of purities within a tumour (‘Tumour Purity Difference’) and the degree of SCNA subclonality (LME coefficient = 0.28, LME ANOVA p = 0.04, adjusted, S9B Fig ), indicating that tumour purity may interfere with the estimation of SCNA clonality.
nominally significantp = 0.040.8× alphagold
Longitudinal change in total recall performance was nominally significant ( p = 0.04) between the PiB + and PiB − groups, and total recall at baseline was also significantly different between groups ( p < 0.01) indicating, as expected, a more overt cognitive decline was present in the individuals with positive PiB scans.
a significant trendp = 0.040.8× alphagold
A significant trend to an overrepresentation of unfavourable FAB types in CD105 hi AMLs was observed (3 vs. 10 patients; p = 0.04), while increased WBC was significantly associated with the CD105 hi cohort (mean WBC 78.4 vs. 142 G/L; p = 0.009).
a positive trendP = 0.040.8× alphagold
Interestingly, in this cohort of patients, a positive trend in mRFS (86.9 versus 32.6 months, P = 0.04) was noticed in patients who received a prolonged treatment with a multidrug regimen (e.g. anthracycline with cyclophosphamide or ifosfamide and vincristine followed by or alternated with etoposide and ifosfamide) compared with those treated with anthracycline and ifosfamide only.